Biological Products, (No Diagnostic Substances) · DE · CIK 1841387
Developing off-the-shelf viral immunotherapies to elicit individualized, systemic anti-tumor immune responses against cancer
Comparable business profile · signals at a glance
In the 90 days to Feb 23, 2026: 1 insider bought $3.0M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 23, 2026 | Manning Paul BDirector | Buy | 550,458 | $5.45 | $3.0M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.